Business, energy, technology, markets and global industry news from Business News Today

short bowel syndrome

PharmaDeviceNews short bowel syndrome
Representative image showing a biotech licensing discussion around long-acting GLP-2 therapy, reflecting Lilly and Hanmi Pharm’s sonefpeglutide deal for short bowel syndrome treatment.
Pharma & Biotech

Can Lilly turn Hanmi’s sonefpeglutide into the next long-acting GLP-2 rare disease bet?

Read why Lilly’s Hanmi sonefpeglutide deal could reshape long-acting GLP-2 therapy for short bowel syndrome.

Read More
Pharma & Biotech

Alcresta’s RELiZORB shows BMI and weight gains in pediatric tube-fed patients

See how RELiZORB improved weight and BMI z-scores in tube-fed children aged 1–5 in new real-world data. Explore what this means for pediatric care today.

Read More